NovoLog® is the first rapid-acting insulin with an extended in-use time in external insulin pump reservoirs.a
NovoLog® in insulin pump therapy1
Stable with pump therapy
Change
Time frame (up to)
Change
Time frame (up to)
Infusion setb and infusion set insertion site
3 days2
NovoLog® in pump reservoir
6 days2
aNovoLog® in pump reservoir should be discarded at least every 6 days of use or after exposure to temperatures that exceed 98.6˚F (37˚C). The infusion set and infusion set insertion site should be changed at least every 3 days.
bFollow manufacturer’s instructions.
Extended in-use time compared with insulin glulisine2,3
NovoLog® has 4 more days of in-use time vs insulin glulisine.
In-use time
Time frame (up to)
In-use time
Insulin glulisine
2 days
NovoLog®
6 days
It is recommended that patients using an insulin pump have a back-up source for insulin.
